PESB recommends the name of Saravanan U for NFL's CMD post 
Latest News

PESB recommends the name of Saravanan U for NFL’s CMD post

The Public Enterprises Selection Board (PESB) panel has recommended the name of Saravanan U for the post of Chairman & Managing Director (CMD) of National Fertilizers Limited (NFL)

PSU Watch Bureau

New Delhi: Saravanan U is set to be the next Chairman & Managing Director (CMD) of National Fertilizers Limited (NFL), a Miniratna PSU under the Department of Fertilizers. He has been recommended for the post by the Public Enterprises Selection Board (PESB) panel on Friday. Presently, he is serving as CMD of Madras Fertilizers Limited (MFL).

The NFL's CMD post fell vacant after its former head Virendra Nath Datt superannuated in June 2022. Since then, NFL's Director (Marketing) has been holding the additional charge of the post.

Saravanan has been recommended for the post of CMD of NFL from a list of two candidates, who were interviewed by the PESB panel in its selection meeting held on February 3, 2023. Another candidate was from NFL.

As CMD of NFL, Saravanan will be the Chief Executive of the corporation and shall be accountable to its board of directors and the government. He will also be responsible for the efficient functioning of the corporation for achieving its corporate objectives and performance parameters.

(PSU Watch– India's Business News centre that places the spotlight on PSUs, Bureaucracy, Defence and Public Policy is now on Google News. Click here to follow. Also, join PSU Watch Channel in your Telegram. You may also follow us on Twitter here and stay updated.)h7

Rupee strengthens against US dollar as foreign inflows, softer crude prices support sentiment

Sensex surges over 1,000 points, Nifty tops 25,300 as FII inflows, strong Q2 earnings fuel rally

Karnataka expects data centre demand to add another 1,000 MW in 4-5 years: Additional Chief Secretary

PESB recommends Jobi VP for CCL's Director (Personnel) post

Govt invites fresh applications under PLI scheme for medical devices; extends tenure till 2035-36